TapewireFind a company

person · Reporting owner

Sullivan Daniel

Disclosed activity across 3 companies

Tapewire entity
56613
SEC CIK
0001682440

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
FIVE BELOW, INCFIVE · Entity 3393Chief Financial OfficerOctober 06, 2026October 08, 2026
Party City Holdco Inc.PRTY · Entity 108808Chief Financial OfficerApril 20, 2018April 24, 2018

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

FIVE BELOW, INC

Report date October 06, 2026 · Filed October 08, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect14,069 Reported balance After 2026-10-06 transaction · row 1
1 source row

Row 1 · 2026-10-06 · Tax withholding · Disposed 2,006 · Balance 14,069

Party City Holdco Inc.

Report date April 20, 2018 · Filed April 24, 2018

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common stock, par value $0.01 per share ("Common Stock")SEC Table I · non-derivativeDirect7,455 Reported balance After 2018-04-20 transaction · row 1
1 source row

Row 1 · 2018-04-20 · Grant · Acquired 7,455 · Balance 7,455

F1: The shares reported are restricted shares of Common Stock granted to the reporting person on April 20, 2018, under the Company's Amended and Restated 2012 Omnibus Equity Incentive Plan. The restricted shares shall vest in three equal annual installments commencing on April 20, 2019.

Filing footnotes · ownership attribution and instrument terms

F1: The shares reported are restricted shares of Common Stock granted to the reporting person on April 20, 2018, under the Company's Amended and Restated 2012 Omnibus Equity Incentive Plan. The restricted shares shall vest in three equal annual installments commencing on April 20, 2019.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

EDGEWELL PERSONAL CARE Co

Report date October 01, 2025 · Filed October 02, 2025

Section 16 reporting ended · disclosed 2025-10-02. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Non-Qualified Stock Options 11-11-2022SEC Table II · derivative / convertible security · Conversion / exercise price $39.75 · Expires 2032-11-11Direct12,265 Reported balance After 2025-10-01 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2025-10-01 · Other · Disposed 6,132 · Balance 12,265

F1: Unvested award forfeited upon Mr. Sullivan's departure from the Company on October 1, 2025.

F2: These options were vested prior to Mr. Sullivan's departure from the Company. He has 90 days from his departure date to exercise them.

Non-Qualified Stock Options 11/12/2021SEC Table II · derivative / convertible security · Conversion / exercise price $43.29 · Expires 2031-11-12Direct16,428 Reported balance After 2025-10-01 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2025-10-01 · Other · Disposed 0 · Balance 16,428

F3: There were no unvested options for this award to forfeit at the time of Mr. Sullivan's departure from the Company. This is the number of vested and exercisable options that he has 90 days to exercise from the date of his departure.

Non-Qualified Stock Options 11/13/2020SEC Table II · derivative / convertible security · Conversion / exercise price $35.37 · Expires 2030-11-13Direct8,857 Reported balance After 2025-10-01 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2025-10-01 · Other · Disposed 0 · Balance 8,857

F3: There were no unvested options for this award to forfeit at the time of Mr. Sullivan's departure from the Company. This is the number of vested and exercisable options that he has 90 days to exercise from the date of his departure.

Non-Qualified Premium Stock Options 11/13/2020SEC Table II · derivative / convertible security · Conversion / exercise price $38.91 · Expires 2030-11-13Direct18,535 Reported balance After 2025-10-01 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2025-10-01 · Other · Disposed 0 · Balance 18,535

F3: There were no unvested options for this award to forfeit at the time of Mr. Sullivan's departure from the Company. This is the number of vested and exercisable options that he has 90 days to exercise from the date of his departure.

Non-Qualified Stock Options 11/14/2019SEC Table II · derivative / convertible security · Conversion / exercise price $31.44 · Expires 2029-11-14Direct23,580 Reported balance After 2025-10-01 transaction · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · 2025-10-01 · Other · Disposed 0 · Balance 23,580

F3: There were no unvested options for this award to forfeit at the time of Mr. Sullivan's departure from the Company. This is the number of vested and exercisable options that he has 90 days to exercise from the date of his departure.

Non-Qualified Stock Options 11/10/2023SEC Table II · derivative / convertible security · Conversion / exercise price $34.22 · Expires 2033-11-10Direct6,924 Reported balance After 2025-10-01 transaction · row 7 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 7 · 2025-10-01 · Other · Disposed 13,848 · Balance 6,924

F1: Unvested award forfeited upon Mr. Sullivan's departure from the Company on October 1, 2025.

F2: These options were vested prior to Mr. Sullivan's departure from the Company. He has 90 days from his departure date to exercise them.

Restricted Stock Equivalent 11/11/2022SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2025-11-11Direct0 Reported balance After 2025-10-01 transaction · row 8 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 8 · 2025-10-01 · Other · Disposed 3,522 · Balance 0

F1: Unvested award forfeited upon Mr. Sullivan's departure from the Company on October 1, 2025.

Restricted Stock Equivalent 11/10/2023SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2026-11-10Direct0 Reported balance After 2025-10-01 transaction · row 9 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 9 · 2025-10-01 · Other · Disposed 8,182 · Balance 0

F1: Unvested award forfeited upon Mr. Sullivan's departure from the Company on October 1, 2025.

Restricted Stock Equivalent 11/8/2024SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2027-11-08Direct0 Reported balance After 2025-10-01 transaction · row 10 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 10 · 2025-10-01 · Other · Disposed 17,700 · Balance 0

F1: Unvested award forfeited upon Mr. Sullivan's departure from the Company on October 1, 2025.

Performance Restricted Stock Equivalent 11/11/2022SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2025-11-11Direct0 Reported balance After 2025-10-01 transaction · row 11 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 11 · 2025-10-01 · Other · Disposed 35,221 · Balance 0

F1: Unvested award forfeited upon Mr. Sullivan's departure from the Company on October 1, 2025.

Performance Restricted Stock Equivalent 11/10/2023SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2026-11-10Direct0 Reported balance After 2025-10-01 transaction · row 12 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 12 · 2025-10-01 · Other · Disposed 40,912 · Balance 0

F1: Unvested award forfeited upon Mr. Sullivan's departure from the Company on October 1, 2025.

Performance Restricted Stock Equivalent 11/8/2024SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2027-11-11Direct0 Reported balance After 2025-10-01 transaction · row 13 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 13 · 2025-10-01 · Other · Disposed 53,098 · Balance 0

F1: Unvested award forfeited upon Mr. Sullivan's departure from the Company on October 1, 2025.

Common StockSEC Table I · non-derivativeDirect90,418 Reported balance Holding disclosure · report date 2025-10-01 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 90,418

Filing footnotes · ownership attribution and instrument terms

F1: Unvested award forfeited upon Mr. Sullivan's departure from the Company on October 1, 2025.

F2: These options were vested prior to Mr. Sullivan's departure from the Company. He has 90 days from his departure date to exercise them.

F3: There were no unvested options for this award to forfeit at the time of Mr. Sullivan's departure from the Company. This is the number of vested and exercisable options that he has 90 days to exercise from the date of his departure.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
April 01, 2019 Filed Apr 3, 2019 12:49 UTC EDGEWELL PERSONAL CARE Co EPC · Entity 4787 GrantPerformance Stock Equivalents (PSE) 4/1/2019 · Derivative 45,106 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-19-022898 · doc4.xml · derivative · entry 2

Sullivan Daniel · CIK 0001682440 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,106

Underlying: Common Stock · 45,106 shares

Expires not disclosed

F2 · derivative.exercise_date: The PSEs will vest and convert into shares of Edgewell common stock on the date that Edgewell releases its earnings for the fiscal year ending September 30, 2021 if specified performance criteria are met, subject to the exercise of negative discretion by the Compensation Committee of Edgewell's Board of Directors. The performance goal for the PSEs is the achievement of targeted Project Fuel savings for the period ended September 30, 2021. The percentage of the PSEs vesting will range from 0% to 100% based on performance.

F2 · derivative.expiration_date: The PSEs will vest and convert into shares of Edgewell common stock on the date that Edgewell releases its earnings for the fiscal year ending September 30, 2021 if specified performance criteria are met, subject to the exercise of negative discretion by the Compensation Committee of Edgewell's Board of Directors. The performance goal for the PSEs is the achievement of targeted Project Fuel savings for the period ended September 30, 2021. The percentage of the PSEs vesting will range from 0% to 100% based on performance.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 12:49 UTC EDGEWELL PERSONAL CARE Co EPC · Entity 4787 GrantRestricted Stock Equivalents (RSE) 4/1/2019 · Derivative 11,277 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-19-022898 · doc4.xml · derivative · entry 1

Sullivan Daniel · CIK 0001682440 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,277

Underlying: Common Stock · 11,277 shares

Expires not disclosed

F1 · derivative.exercise_date: One-half of the RSEs will vest and convert into shares of Edgewell common stock on each of 4/1/2020 and 4/1/2021 if the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events.

F1 · derivative.expiration_date: One-half of the RSEs will vest and convert into shares of Edgewell common stock on each of 4/1/2020 and 4/1/2021 if the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events.

Read SEC document
April 20, 2018 Filed Apr 24, 2018 17:45 UTC Party City Holdco Inc. PRTY · Entity 108808 GrantCommon stock, par value $0.01 per share ("Common Stock") 7,455 $0.00 $0.00
Disclosure

SEC source: 0000904454-18-000305 · edgar.xml · nonDerivative · entry 1

Sullivan Daniel · CIK 0001682440 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,455

F1 · shares: The shares reported are restricted shares of Common Stock granted to the reporting person on April 20, 2018, under the Company's Amended and Restated 2012 Omnibus Equity Incentive Plan. The restricted shares shall vest in three equal annual installments commencing on April 20, 2019.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.